HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 244 filers reported holding HAEMONETICS CORP in Q2 2022. The put-call ratio across all filers is 1.27 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $650,709 | +3.5% | 7,264 | -1.6% | 0.01% | +12.5% |
| Q2 2023 | $628,418 | -3.2% | 7,381 | -6.0% | 0.01% | -11.1% |
| Q1 2023 | $649,505 | +4.8% | 7,849 | -0.4% | 0.01% | -10.0% |
| Q4 2022 | $619,998 | +5.3% | 7,883 | -1.0% | 0.01% | -9.1% |
| Q3 2022 | $589,000 | +13.7% | 7,959 | +0.1% | 0.01% | +10.0% |
| Q2 2022 | $518,000 | +10.2% | 7,949 | +6.9% | 0.01% | +25.0% |
| Q1 2022 | $470,000 | +18.1% | 7,436 | -0.9% | 0.01% | +33.3% |
| Q4 2021 | $398,000 | -25.6% | 7,504 | -1.1% | 0.01% | -40.0% |
| Q3 2021 | $535,000 | +0.4% | 7,586 | -5.2% | 0.01% | 0.0% |
| Q2 2021 | $533,000 | -53.5% | 8,002 | -22.5% | 0.01% | -58.3% |
| Q1 2021 | $1,146,000 | -4.6% | 10,319 | +2.0% | 0.02% | -7.7% |
| Q4 2020 | $1,201,000 | +36.0% | 10,115 | -0.1% | 0.03% | +18.2% |
| Q3 2020 | $883,000 | +5.5% | 10,121 | +8.3% | 0.02% | 0.0% |
| Q2 2020 | $837,000 | – | 9,342 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BEACONLIGHT CAPITAL, LLC | 95,033 | $8,511,000 | 2.84% |
| Advantage Alpha Capital Partners LP | 100,170 | $8,971,000 | 2.10% |
| Nitorum Capital, L.P. | 395,635 | $35,433,000 | 1.82% |
| Summit Creek Advisors LLC | 127,600 | $11,428,000 | 1.68% |
| Bridge City Capital, LLC | 40,559 | $3,632,000 | 1.67% |
| AEGON ASSET MANAGEMENT UK PLC | 520,408 | $46,603,000 | 1.05% |
| Jackson Square Partners, LLC | 2,298,190 | $205,825,000 | 1.03% |
| Parkman Healthcare Partners LLC | 30,147 | $2,700,000 | 0.76% |
| TEALWOOD ASSET MANAGEMENT INC | 9,154 | $820,000 | 0.54% |
| AMERICAN CAPITAL MANAGEMENT INC | 159,145 | $14,253,000 | 0.52% |